Drug Profile
CDT-raloxifene - SCOLR Pharma
Alternative Names: CDT®-raloxifene; Controlled Delivery Technology®-raloxifeneLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator SCOLR Pharma
- Class Antineoplastics; Calcium regulators; Osteoporosis therapies; Small molecules; Stilbenes
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Osteoporosis